M
Matthias Port
Researcher at University of Ulm
Publications - 149
Citations - 2158
Matthias Port is an academic researcher from University of Ulm. The author has contributed to research in topics: Medicine & Biodosimetry. The author has an hindex of 21, co-authored 122 publications receiving 1560 citations. Previous affiliations of Matthias Port include Hannover Medical School & Hochschule Hannover.
Papers
More filters
Journal Article
Overexpression of Glucose Transporter 1 and Increased FDG Uptake in Pancreatic Carcinoma
Sven N. Reske,Kurt G. Grillenberger,Gerhard Glatting,Matthias Port,Martin Hildebrandt,Frank Gansauge,Hans-Günther Beger +6 more
TL;DR: The concomitant enhancement of glucose utilization and selective overexpression of GlUT-1 mRNA in pancreatic cancer but not in MFP suggested constitutive activation of Glut-1 gene or decreased degradation ofglucose metabolism in human pancreaticcancer.
Journal ArticleDOI
Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.
Li Xu,Matthias Port,Stefano Landi,Federica Gemignani,Monica Cipollini,Rossella Elisei,Lilia Goudeva,Jörg A. Müller,Kai Nerlich,Giovanni Pellegrini,Christoph Reiners,Cristina Romei,Robert Schwab,Michael Abend,Erich M. Sturgis +14 more
TL;DR: Anthropometric factors, especially BMI and body fat percentage, were significantly associated with increased risk of PTC.
Journal ArticleDOI
Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis
Matthias Port,M. Böttcher,Felicitas Thol,Arnold Ganser,RF Schlenk,Jürgen Wasem,A. Neumann,L Pouryamout +7 more
TL;DR: Meta-analysis for overall survival (OS) and relapse-free survival (RFS) showed FLT3-ITD to predict an unfavorable prognosis, whereas mutations in NPM1 and CEBPA genes were associated with a favorable prognosis.
Journal ArticleDOI
FDXR is a biomarker of radiation exposure in vivo
Grainne O’Brien,Lourdes Cruz-Garcia,Matthäus Majewski,Jakub Grepl,Michael Abend,Matthias Port,Aleš Tichý,Igor Sirák,Andrea Malkova,Ellen M. Donovan,Lone Gothard,Sue Boyle,Navita Somaiah,Elizabeth A. Ainsbury,Lucyna Ponge,Krzysztof Slosarek,Leszek Miszczyk,Piotr Widlak,Edward W. Green,Neel Patel,Mahesh Kudari,Fergus V. Gleeson,Volodymyr A. Vinnikov,Viktor Starenkiy,Sergii Artiukh,Leonid Vasyliev,Azfar Zaman,Christophe Badie +27 more
TL;DR: The remarkable responsiveness of FDXR to ionising radiation at the transcriptional level which, when measured in the right time window, provides accurate in vivo dose estimates is reported.
Journal ArticleDOI
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
Matthias Port,Stephanie Glaesener,Christian Ruf,Armin Riecke,Carsten Bokemeyer,Viktor Meineke,Friedemann Honecker,Michael Abend +7 more
TL;DR: Examining almost all known human microRNA species confirmed the miR-371-373 cluster as a promising target for explaining cisplatin resistance, potentially by counteracting wild-type P53 induced senescence or linking it with the potency to differentiate.